news
Fourth-quarter and anticipated future results for demand, retention, pricing, and expenses came in well above very low expectations for Strayer Eductation (NASDAQ:STRA), which should lead to significant upward moves in consensus forward earnings estimates. When combined with very weak sentiment following four years of virtually uninterrupted bad news and an associated 91% decline in peak-to-trough…
Sodastream International (NASDAQ: SODA) was volatile in pre-market trade after reporting Q4 earnings that fell less than expected and as the FY sales guidance was short of analysts’ estimates. Having earlier trading higher by as much as 3% in pre-market trade, the stock was recently down 0.2% at $39.00. The maker of home beverage carbonation…
Shares of Barnes & Noble (NYSE:BKS) climbed in Wednesday’s pre-market session, after the bookseller reported it swung to a higher-than-expected fiscal Q3 profit, with sales matching analysts’ estimates. In addition, Chief Executive Michael P. Huseby said the company is “actively engaged in discussions with several world-class hardware partners related to device development as well as…
Tesla (NASDAQ:TSLA) is posting gains in early pre-market trade Wednesday, gaining momentum in the wake of reports the company is in talks with Panasonic about investing nearly $1 billion in a battery factory in the U.S. Panasonic said it was considering various options to strengthen its ties with Tesla, according to multiple media reports citing…
Copart, Inc. (NASDAQ:CPRT), provider of online auctions and vehicle remarketing services, reported late on Tuesday Q2 2014 net income of $45.3 million, or $0.35 per diluted share. If comparable, it would have been 2 cents shy of the Capital IQ consensus. Year-ago net income was $39.6 million, or $0.31 per diluted share. Revenue increased 7.6%…
Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) are up 17.3%, positioning for a new 52-week high of $40.99 if the gains should hold into Wednesday. The stock just came off an evening-session halt after the company said it received FDA marketing approval for MONOVISC, a single injection supplement to synovial fluid of the osteoarthritic joint, used…
